In vitro diagnostics (IVD) have become indispensable in modern healthcare, helping clinicians diagnose, monitor, and treat diseases precisely. These tests are crucial in patient care, from detecting infectious diseases to assessing chronic conditions. But behind every accurate and reliable test lies a robust system of quality controls (QCs), ensuring that these diagnostic tools deliver consistent and trustworthy results.
As the global In vitro diagnostics market expands, quality controls are becoming more critical than ever.
According to BCC Research, the global market for in vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 to $2.1 billion by the end of 2029 at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.
In vitro diagnostics quality controls are reference materials used to validate the accuracy and precision of diagnostic tests. They simulate patient samples and are tested alongside specimens to ensure the diagnostic process functions correctly. These controls can detect deviations or errors in the test results, allowing laboratories to make necessary adjustments before analyzing patient samples.
With adequate quality controls, the reliability of diagnostic tests could be protected, leading to misdiagnosis, incorrect treatment plans, and potentially harmful outcomes for patients.